Venous Thromboembolism Treatment Market

Venous Thromboembolism Treatment Market Outlook from 2024 to 2034

The venous thromboembolism treatment market is projected to be valued at USD 1,760.42 million in 2024 and is expected to increase to USD 2,580.90 million by 2034, representing a CAGR of 3.9% during the forecast period.

Key Market Drivers:

• Factors such as aging populations, sedentary lifestyles, obesity, and increasing surgical procedures contribute to the growing prevalence of venous thromboembolism.
• Efforts by healthcare organizations, patient advocacy groups, and government initiatives to raise awareness about venous thromboembolism and its treatment options contribute to market expansion.
• As more individuals access healthcare services, the greater demand for venous thromboembolism treatment options leads to market expansion.
• The global demographic trend of an aging population significantly drives the venous thromboembolism (VTE) treatment market.
• Elderly individuals are at a higher risk of developing venous thromboembolism due to age-related factors, such as reduced mobility, comorbidities, and changes in blood composition, driving market expansion.
• Favorable healthcare policies and reimbursement frameworks encourage investment in venous thromboembolism treatment options, fueling demand for venous thromboembolism treatment.
• Pharmaceutical and medical device companies engage in continuous research and development activities to create innovative treatment options. These include oral anticoagulants, injectable thrombolytics, and mechanical thrombectomy devices. They stimulate market growth by offering improved treatment efficacy and patient outcomes.

Attributes	Key Statistics
Estimated Venous Thromboembolism Treatment Market Value (2024)	USD 1,760.42 million
Forecasted Market Value (2034)	USD 2,580.90 million
Projected Growth Rate (2024 to 2034)	3.9% CAGR

Demand Analysis of Venous Thromboembolism Treatments

• Ongoing advancements in treatment technologies, such as novel anticoagulants, catheter-directed thrombolysis, and compression therapy, are expanding the available treatment options for venous thromboembolism patients. Healthcare providers and patients increasingly favor these advanced treatment options, contributing to market expansion.
• Pharmaceutical companies are experiencing an increase in sales of venous thromboembolism therapeutics, driven by heightened demand and expanding patient populations, leading to revenue growth in the market.
• The market is witnessing widespread adoption of innovative technologies, such as mechanical thrombectomy devices, leading to increased treatment efficacy and fueling market growth.
• Healthcare professionals recognize the importance of timely diagnosis and treatment of venous thromboembolism, leading to greater emphasis on the management of venous thromboembolism and boosting the market's popularity within the medical community.
• Greater patient awareness about the risks associated with venous thromboembolism and the availability of effective therapies drive patient demand, prompting healthcare providers to offer various treatment options.

Restraining Factors Adversely Affecting the Venous Thromboembolism Treatment Market

The market is anticipated to surpass a valuation of USD 2,580.90 million by 2034, with a growth rate of 3.9% CAGR. Despite experiencing growth, several restraining factors can adversely affect its development and expansion.

• The cost of VTE treatments is high, limiting access to care for certain patient populations, particularly in low-income regions or for individuals without adequate insurance coverage.
• Despite advancements in treatment options, VTE therapies carry a risk of bleeding and other adverse side effects.
• There may still be gaps in understanding among patients and healthcare professionals regarding VTE risk factors, symptoms, and treatment options, leading to delayed diagnosis and suboptimal management, restraining market growth.
• Stringent regulatory requirements for approving new VTE treatments can prolong the time to market entry.
• Some patients and healthcare providers may prefer traditional VTE treatments over newer agents due to familiarity, perceived efficacy, or cost considerations, limiting the adoption of further treatment options and impacting market growth.
• VTE is often underdiagnosed and undertreated, particularly in settings with limited access to healthcare resources or where VTE risk assessment is not routinely performed.
• The complexity of VTE treatment regimens, including the need for long-term anticoagulation therapy and monitoring, as well as the potential for drug interactions and dosing adjustments, adds to the challenges.

Category-wise Insights

Rising Prevalence and Serious Complications Cement Deep Vein Thrombosis's Market Dominance

Based on its indications, deep vein thrombosis dominates the venous thromboembolism treatment market with a share of 62.00% in 2024. This rising popularity is attributed to:

• Deep vein thrombosis (DVT) occurs when a blood clot forms in one of the body's deep veins, typically in the legs, and can lead to life-threatening conditions like pulmonary embolism if left untreated.
• Deep vein thrombosis significantly affects healthcare resources and costs as it necessitates hospitalization, diagnostic imaging, and long-term anticoagulation therapy.
• Healthcare providers prioritize preventing, diagnosing, and treating deep vein thrombosis due to its substantial burden on healthcare systems and the economy.
• Pharmaceutical companies and medical device manufacturers also focus on developing innovative therapies and interventions for DVT management.

Attributes	Details
Indication	Deep Vein Thrombosis
Market Share in 2024	62.00%

Hospitals Surge Ahead in Market Dominance with Acute Care, Specialized Expertise, and Diagnostic Resources

Based on its end user, hospitals rule the venous thromboembolism treatment market with a share of 38.90% in 2024. This rising popularity is attributed to:

• Hospitals are the primary settings for diagnosing, managing, and treating VTE, which can be life-threatening if not treated immediately.
• Hospitals play a crucial role in providing acute care services, such as administering anticoagulant therapy, performing surgical interventions, and monitoring patients' responses to treatment.
• Hospitals' access to a wide range of specialized medical professionals and resources, including vascular surgeons, interventional radiologists, hematologists, and nursing staff trained in thrombosis care, ensures comprehensive VTE management. They also have necessary diagnostic equipment, such as Doppler ultrasound machines and CT scanners, to accurately diagnose VTE and assess its severity.
• Hospitals typically maintain formularies of anticoagulant medications and thrombolytic agents, enabling timely initiation of treatment protocols following VTE diagnosis.

Attributes	Details
End User	Hospitals
Market Share in 2024	38.90%

Country-wise Insights

The section analyzes the venous thromboembolism treatment market by country, including the United Kingdom, China, and India. The table presents the CAGR for each country, indicating the expected market growth in that country through 2034.

Countries	Forecasted Market CAGR from 2024 to 2034
India	4.80%
China	4.10%
United Kingdom	4.60%

India's Rising Prevalence of Sedentary Lifestyles and Obesity Sparks Market Growth

India leads among Asian countries in the venous thromboembolism treatment market, with an anticipated CAGR of 4.80% through 2034.

• The government's focus on enhancing healthcare infrastructure and improving access to healthcare services, coupled with a thriving pharmaceutical industry, promotes market growth in India.
• Government initiatives aimed at promoting affordable healthcare solutions, such as the Ayushman Bharat program, are key drivers of market expansion.
• The emphasis on patient education and raising awareness about the importance of VTE prevention and treatment also contributes significantly to the market's growth.

China's Rapidly Growing Elderly Population is More Prone to VTE-related Conditions

China is another Asian country holding a strong position in the venous thromboembolism treatment market. The market in China is anticipated to register a CAGR of 4.10% through 2034.

• China's advancements in medical technology and rising awareness among healthcare professionals and patients about the importance of VTE prevention and treatment contribute to the market's growth.
• The government focuses on enhancing healthcare infrastructure and access to treatment in China, along with initiatives aimed at promoting affordable healthcare solutions, which lead to market growth.

United Kingdom's Advanced Healthcare Infrastructure Mark Innovative Treatment Options

The United Kingdom leads among European countries in the venous thromboembolism treatment market and is predicted to register a compound annual growth rate of 4.60% through 2034.

• The United Kingdom's advanced healthcare infrastructure, comprehensive national healthcare system (NHS), and emphasis on preventive care and early intervention thrive in the market.
• Medical research facilities in the United Kingdom and collaborations between academia and industry promote innovation in VTE treatment options.
• The aging population in the United Kingdom and the increasing prevalence of obesity and other risk factors significantly contribute to the market's growth.
• The focus in the United Kingdom on educating patients and creating awareness about VTE prevention and treatment is also a crucial factor driving market growth.

Competitive Landscape of the Thromboembolism Treatment Market

The demand for the treatment of venous thromboembolism continues to grow, leading companies and manufacturers such as Argon Medical Devices to focus on developing and improving inferior vena cava (IVC) filters. These filters prevent patients from experiencing pulmonary embolism and other VTE complications. These companies are investing heavily in research and development to create new filter designs that prioritize safety, efficacy, and ease of retrieval.

Manufacturers are also expanding their global presence by forming partnerships, collaborations, and distribution networks to ensure their products are widely available and meet the growing demand for VTE treatments worldwide. These initiatives are expected to drive significant growth and improve patient outcomes while globally reducing the burden of VTE-related morbidity and mortality.

Recent Developments:

• Thrombectomy use increased to treat VTE, reported research at the RSNA meeting on November 30, 2023. Over the past five years, arterial and venous thrombectomy saw significant utilization growth, marking a notable trend in addressing blood clots.
• In July 2021, Prof. Jeffrey Weitz reported that a study found abelacimab, a new VTE treatment, reduced VTE rates by 80% compared to enoxaparin after total knee arthroplasty. Weitz stated it's an attractive therapy due to its effectiveness and reduced risk of bleeding.
• At the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2022 annual meeting, held from September 10-14 in Barcelona, Spain, Gerd Grözinger and Bernhard Gebauer discussed challenges in treating pulmonary embolism (PE) and deep vein thrombosis (DVT). Gebauer highlighted limited options with anticoagulation or lysis.

Key Companies in the Market

• Stryker Corporation
• Argon Medical Devices
• Cardinal Health (Medtronic)
• Cook Medical
• Boston Scientific Corporation
• Koninklijke Philips N.V.
• Arjo
• DJO Global

Key Coverage in the Venous Thromboembolism Treatment Market Report

• Top 3 Blood Thinners in Venous Thromboembolism Treatment Market
• Comparative Studies of ASH Venous Thromboembolism Treatment
• Ongoing Trends in the Management of Venous Thromboembolism
• Insights into the Best Treatment for Vein Thrombosis
• Advances in the Diagnosis and Treatment of Venous Thromboembolism
• Opportunity Analysis in Medications for Deep Venous Thrombosis

Table of Content

• 1. Executive Summary
• 2. Market Overview
• 3. Market Background
• 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
• 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product
  • 5.1. Non-Segmented Pneumatic Compression Pumps
  • 5.2. Segmented Pneumatic Compression Pumps without Gradient
  • 5.3. Segmented Pneumatic Compression Pumps with Calibrated Gradient
  • 5.4. Upper Pneumatic Compression Sleeves
  • 5.5. Lower Pneumatic Compression Sleeves
  • 5.6. Permanent Inferior Vena Cava Filters
  • 5.7. Retrievable Inferior Vena Cava Filters
  • 5.8. Embolectomy Balloon Catheters
  • 5.9. Percutaneous Thrombectomy Devices
  • 5.10. Catheter-Directed Thrombolysis (CDT) Devices
• 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Disease Indication
  • 6.1. Deep Venous Thrombosis
  • 6.2. Pulmonary Embolism
• 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User
  • 7.1. Hospitals
  • 7.2. Catheterisation Laboratories
  • 7.3. Ambulatory Surgical Centres
• 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
  • 8.1. North America
  • 8.2. Latin America
  • 8.3. Western Europe
  • 8.4. Eastern Europe
  • 8.5. South Asia and Pacific
  • 8.6. East Asia
  • 8.7. Middle East and Africa
• 9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 16. Key Countries Market Analysis
• 17. Market Structure Analysis
• 18. Competition Analysis
  • 18.1. Competition Deep Dive
  • 18.2. AngioDynamics
  • 18.3. Cardinal Health Inc.
  • 18.4. BTG International Ltd.
  • 18.4.5. Strategy Overview
  • 18.5. Stryker Corporation
  • 18.6. DJO Global Inc.
  • 18.7. EKOS Corp
  • 18.8. Boston Scientific Corporation
  • 18.9. Janssen Pharmaceuticals, Inc
  • 18.10. Argon Medical Devices
• 19. Assumptions & Acronyms Used
• 20. Research Methodology

List of Tables

Table 1: Global Market Value (US$ Million) Forecast by Region, 2019 to 2034

Table 2: Global Market Volume (Units) Forecast by Region, 2019 to 2034

Table 3: Global Market Value (US$ Million) Forecast by Product, 2019 to 2034

Table 4: Global Market Volume (Units) Forecast by Product, 2019 to 2034

Table 5: Global Market Value (US$ Million) Forecast by Disease Indication, 2019 to 2034

Table 6: Global Market Volume (Units) Forecast by Disease Indication, 2019 to 2034

Table 7: Global Market Value (US$ Million) Forecast by End User, 2019 to 2034

Table 8: Global Market Volume (Units) Forecast by End User, 2019 to 2034

Table 9: North America Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 10: North America Market Volume (Units) Forecast by Country, 2019 to 2034

Table 11: North America Market Value (US$ Million) Forecast by Product, 2019 to 2034

Table 12: North America Market Volume (Units) Forecast by Product, 2019 to 2034

Table 13: North America Market Value (US$ Million) Forecast by Disease Indication, 2019 to 2034

Table 14: North America Market Volume (Units) Forecast by Disease Indication, 2019 to 2034

Table 15: North America Market Value (US$ Million) Forecast by End User, 2019 to 2034

Table 16: North America Market Volume (Units) Forecast by End User, 2019 to 2034

Table 17: Latin America Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 18: Latin America Market Volume (Units) Forecast by Country, 2019 to 2034

Table 19: Latin America Market Value (US$ Million) Forecast by Product, 2019 to 2034

Table 20: Latin America Market Volume (Units) Forecast by Product, 2019 to 2034

Table 21: Latin America Market Value (US$ Million) Forecast by Disease Indication, 2019 to 2034

Table 22: Latin America Market Volume (Units) Forecast by Disease Indication, 2019 to 2034

Table 23: Latin America Market Value (US$ Million) Forecast by End User, 2019 to 2034

Table 24: Latin America Market Volume (Units) Forecast by End User, 2019 to 2034

Table 25: Western Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 26: Western Europe Market Volume (Units) Forecast by Country, 2019 to 2034

Table 27: Western Europe Market Value (US$ Million) Forecast by Product, 2019 to 2034

Table 28: Western Europe Market Volume (Units) Forecast by Product, 2019 to 2034

Table 29: Western Europe Market Value (US$ Million) Forecast by Disease Indication, 2019 to 2034

Table 30: Western Europe Market Volume (Units) Forecast by Disease Indication, 2019 to 2034

Table 31: Western Europe Market Value (US$ Million) Forecast by End User, 2019 to 2034

Table 32: Western Europe Market Volume (Units) Forecast by End User, 2019 to 2034

Table 33: Eastern Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 34: Eastern Europe Market Volume (Units) Forecast by Country, 2019 to 2034

Table 35: Eastern Europe Market Value (US$ Million) Forecast by Product, 2019 to 2034

Table 36: Eastern Europe Market Volume (Units) Forecast by Product, 2019 to 2034

Table 37: Eastern Europe Market Value (US$ Million) Forecast by Disease Indication, 2019 to 2034

Table 38: Eastern Europe Market Volume (Units) Forecast by Disease Indication, 2019 to 2034

Table 39: Eastern Europe Market Value (US$ Million) Forecast by End User, 2019 to 2034

Table 40: Eastern Europe Market Volume (Units) Forecast by End User, 2019 to 2034

Table 41: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 42: South Asia and Pacific Market Volume (Units) Forecast by Country, 2019 to 2034

Table 43: South Asia and Pacific Market Value (US$ Million) Forecast by Product, 2019 to 2034

Table 44: South Asia and Pacific Market Volume (Units) Forecast by Product, 2019 to 2034

Table 45: South Asia and Pacific Market Value (US$ Million) Forecast by Disease Indication, 2019 to 2034

Table 46: South Asia and Pacific Market Volume (Units) Forecast by Disease Indication, 2019 to 2034

Table 47: South Asia and Pacific Market Value (US$ Million) Forecast by End User, 2019 to 2034

Table 48: South Asia and Pacific Market Volume (Units) Forecast by End User, 2019 to 2034

Table 49: East Asia Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 50: East Asia Market Volume (Units) Forecast by Country, 2019 to 2034

Table 51: East Asia Market Value (US$ Million) Forecast by Product, 2019 to 2034

Table 52: East Asia Market Volume (Units) Forecast by Product, 2019 to 2034

Table 53: East Asia Market Value (US$ Million) Forecast by Disease Indication, 2019 to 2034

Table 54: East Asia Market Volume (Units) Forecast by Disease Indication, 2019 to 2034

Table 55: East Asia Market Value (US$ Million) Forecast by End User, 2019 to 2034

Table 56: East Asia Market Volume (Units) Forecast by End User, 2019 to 2034

Table 57: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 58: Middle East and Africa Market Volume (Units) Forecast by Country, 2019 to 2034

Table 59: Middle East and Africa Market Value (US$ Million) Forecast by Product, 2019 to 2034

Table 60: Middle East and Africa Market Volume (Units) Forecast by Product, 2019 to 2034

Table 61: Middle East and Africa Market Value (US$ Million) Forecast by Disease Indication, 2019 to 2034

Table 62: Middle East and Africa Market Volume (Units) Forecast by Disease Indication, 2019 to 2034

Table 63: Middle East and Africa Market Value (US$ Million) Forecast by End User, 2019 to 2034

Table 64: Middle East and Africa Market Volume (Units) Forecast by End User, 2019 to 2034

List of Figures

Figure 1: Global Market Value (US$ Million) by Product, 2024 to 2034

Figure 2: Global Market Value (US$ Million) by Disease Indication, 2024 to 2034

Figure 3: Global Market Value (US$ Million) by End User, 2024 to 2034

Figure 4: Global Market Value (US$ Million) by Region, 2024 to 2034

Figure 5: Global Market Value (US$ Million) Analysis by Region, 2019 to 2034

Figure 6: Global Market Volume (Units) Analysis by Region, 2019 to 2034

Figure 7: Global Market Value Share (%) and BPS Analysis by Region, 2024 to 2034

Figure 8: Global Market Y-o-Y Growth (%) Projections by Region, 2024 to 2034

Figure 9: Global Market Value (US$ Million) Analysis by Product, 2019 to 2034

Figure 10: Global Market Volume (Units) Analysis by Product, 2019 to 2034

Figure 11: Global Market Value Share (%) and BPS Analysis by Product, 2024 to 2034

Figure 12: Global Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034

Figure 13: Global Market Value (US$ Million) Analysis by Disease Indication, 2019 to 2034

Figure 14: Global Market Volume (Units) Analysis by Disease Indication, 2019 to 2034

Figure 15: Global Market Value Share (%) and BPS Analysis by Disease Indication, 2024 to 2034

Figure 16: Global Market Y-o-Y Growth (%) Projections by Disease Indication, 2024 to 2034

Figure 17: Global Market Value (US$ Million) Analysis by End User, 2019 to 2034

Figure 18: Global Market Volume (Units) Analysis by End User, 2019 to 2034

Figure 19: Global Market Value Share (%) and BPS Analysis by End User, 2024 to 2034

Figure 20: Global Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034

Figure 21: Global Market Attractiveness by Product, 2024 to 2034

Figure 22: Global Market Attractiveness by Disease Indication, 2024 to 2034

Figure 23: Global Market Attractiveness by End User, 2024 to 2034

Figure 24: Global Market Attractiveness by Region, 2024 to 2034

Figure 25: North America Market Value (US$ Million) by Product, 2024 to 2034

Figure 26: North America Market Value (US$ Million) by Disease Indication, 2024 to 2034

Figure 27: North America Market Value (US$ Million) by End User, 2024 to 2034

Figure 28: North America Market Value (US$ Million) by Country, 2024 to 2034

Figure 29: North America Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 30: North America Market Volume (Units) Analysis by Country, 2019 to 2034

Figure 31: North America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 32: North America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 33: North America Market Value (US$ Million) Analysis by Product, 2019 to 2034

Figure 34: North America Market Volume (Units) Analysis by Product, 2019 to 2034

Figure 35: North America Market Value Share (%) and BPS Analysis by Product, 2024 to 2034

Figure 36: North America Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034

Figure 37: North America Market Value (US$ Million) Analysis by Disease Indication, 2019 to 2034

Figure 38: North America Market Volume (Units) Analysis by Disease Indication, 2019 to 2034

Figure 39: North America Market Value Share (%) and BPS Analysis by Disease Indication, 2024 to 2034

Figure 40: North America Market Y-o-Y Growth (%) Projections by Disease Indication, 2024 to 2034

Figure 41: North America Market Value (US$ Million) Analysis by End User, 2019 to 2034

Figure 42: North America Market Volume (Units) Analysis by End User, 2019 to 2034

Figure 43: North America Market Value Share (%) and BPS Analysis by End User, 2024 to 2034

Figure 44: North America Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034

Figure 45: North America Market Attractiveness by Product, 2024 to 2034

Figure 46: North America Market Attractiveness by Disease Indication, 2024 to 2034

Figure 47: North America Market Attractiveness by End User, 2024 to 2034

Figure 48: North America Market Attractiveness by Country, 2024 to 2034

Figure 49: Latin America Market Value (US$ Million) by Product, 2024 to 2034

Figure 50: Latin America Market Value (US$ Million) by Disease Indication, 2024 to 2034

Figure 51: Latin America Market Value (US$ Million) by End User, 2024 to 2034

Figure 52: Latin America Market Value (US$ Million) by Country, 2024 to 2034

Figure 53: Latin America Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 54: Latin America Market Volume (Units) Analysis by Country, 2019 to 2034

Figure 55: Latin America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 56: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 57: Latin America Market Value (US$ Million) Analysis by Product, 2019 to 2034

Figure 58: Latin America Market Volume (Units) Analysis by Product, 2019 to 2034

Figure 59: Latin America Market Value Share (%) and BPS Analysis by Product, 2024 to 2034

Figure 60: Latin America Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034

Figure 61: Latin America Market Value (US$ Million) Analysis by Disease Indication, 2019 to 2034

Figure 62: Latin America Market Volume (Units) Analysis by Disease Indication, 2019 to 2034

Figure 63: Latin America Market Value Share (%) and BPS Analysis by Disease Indication, 2024 to 2034

Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Disease Indication, 2024 to 2034

Figure 65: Latin America Market Value (US$ Million) Analysis by End User, 2019 to 2034

Figure 66: Latin America Market Volume (Units) Analysis by End User, 2019 to 2034

Figure 67: Latin America Market Value Share (%) and BPS Analysis by End User, 2024 to 2034

Figure 68: Latin America Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034

Figure 69: Latin America Market Attractiveness by Product, 2024 to 2034

Figure 70: Latin America Market Attractiveness by Disease Indication, 2024 to 2034

Figure 71: Latin America Market Attractiveness by End User, 2024 to 2034

Figure 72: Latin America Market Attractiveness by Country, 2024 to 2034

Figure 73: Western Europe Market Value (US$ Million) by Product, 2024 to 2034

Figure 74: Western Europe Market Value (US$ Million) by Disease Indication, 2024 to 2034

Figure 75: Western Europe Market Value (US$ Million) by End User, 2024 to 2034

Figure 76: Western Europe Market Value (US$ Million) by Country, 2024 to 2034

Figure 77: Western Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 78: Western Europe Market Volume (Units) Analysis by Country, 2019 to 2034

Figure 79: Western Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 80: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 81: Western Europe Market Value (US$ Million) Analysis by Product, 2019 to 2034

Figure 82: Western Europe Market Volume (Units) Analysis by Product, 2019 to 2034

Figure 83: Western Europe Market Value Share (%) and BPS Analysis by Product, 2024 to 2034

Figure 84: Western Europe Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034

Figure 85: Western Europe Market Value (US$ Million) Analysis by Disease Indication, 2019 to 2034

Figure 86: Western Europe Market Volume (Units) Analysis by Disease Indication, 2019 to 2034

Figure 87: Western Europe Market Value Share (%) and BPS Analysis by Disease Indication, 2024 to 2034

Figure 88: Western Europe Market Y-o-Y Growth (%) Projections by Disease Indication, 2024 to 2034

Figure 89: Western Europe Market Value (US$ Million) Analysis by End User, 2019 to 2034

Figure 90: Western Europe Market Volume (Units) Analysis by End User, 2019 to 2034

Figure 91: Western Europe Market Value Share (%) and BPS Analysis by End User, 2024 to 2034

Figure 92: Western Europe Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034

Figure 93: Western Europe Market Attractiveness by Product, 2024 to 2034

Figure 94: Western Europe Market Attractiveness by Disease Indication, 2024 to 2034

Figure 95: Western Europe Market Attractiveness by End User, 2024 to 2034

Figure 96: Western Europe Market Attractiveness by Country, 2024 to 2034

Figure 97: Eastern Europe Market Value (US$ Million) by Product, 2024 to 2034

Figure 98: Eastern Europe Market Value (US$ Million) by Disease Indication, 2024 to 2034

Figure 99: Eastern Europe Market Value (US$ Million) by End User, 2024 to 2034

Figure 100: Eastern Europe Market Value (US$ Million) by Country, 2024 to 2034

Figure 101: Eastern Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 102: Eastern Europe Market Volume (Units) Analysis by Country, 2019 to 2034

Figure 103: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 104: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 105: Eastern Europe Market Value (US$ Million) Analysis by Product, 2019 to 2034

Figure 106: Eastern Europe Market Volume (Units) Analysis by Product, 2019 to 2034

Figure 107: Eastern Europe Market Value Share (%) and BPS Analysis by Product, 2024 to 2034

Figure 108: Eastern Europe Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034

Figure 109: Eastern Europe Market Value (US$ Million) Analysis by Disease Indication, 2019 to 2034

Figure 110: Eastern Europe Market Volume (Units) Analysis by Disease Indication, 2019 to 2034

Figure 111: Eastern Europe Market Value Share (%) and BPS Analysis by Disease Indication, 2024 to 2034

Figure 112: Eastern Europe Market Y-o-Y Growth (%) Projections by Disease Indication, 2024 to 2034

Figure 113: Eastern Europe Market Value (US$ Million) Analysis by End User, 2019 to 2034

Figure 114: Eastern Europe Market Volume (Units) Analysis by End User, 2019 to 2034

Figure 115: Eastern Europe Market Value Share (%) and BPS Analysis by End User, 2024 to 2034

Figure 116: Eastern Europe Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034

Figure 117: Eastern Europe Market Attractiveness by Product, 2024 to 2034

Figure 118: Eastern Europe Market Attractiveness by Disease Indication, 2024 to 2034

Figure 119: Eastern Europe Market Attractiveness by End User, 2024 to 2034

Figure 120: Eastern Europe Market Attractiveness by Country, 2024 to 2034

Figure 121: South Asia and Pacific Market Value (US$ Million) by Product, 2024 to 2034

Figure 122: South Asia and Pacific Market Value (US$ Million) by Disease Indication, 2024 to 2034

Figure 123: South Asia and Pacific Market Value (US$ Million) by End User, 2024 to 2034

Figure 124: South Asia and Pacific Market Value (US$ Million) by Country, 2024 to 2034

Figure 125: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 126: South Asia and Pacific Market Volume (Units) Analysis by Country, 2019 to 2034

Figure 127: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 128: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 129: South Asia and Pacific Market Value (US$ Million) Analysis by Product, 2019 to 2034

Figure 130: South Asia and Pacific Market Volume (Units) Analysis by Product, 2019 to 2034

Figure 131: South Asia and Pacific Market Value Share (%) and BPS Analysis by Product, 2024 to 2034

Figure 132: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034

Figure 133: South Asia and Pacific Market Value (US$ Million) Analysis by Disease Indication, 2019 to 2034

Figure 134: South Asia and Pacific Market Volume (Units) Analysis by Disease Indication, 2019 to 2034

Figure 135: South Asia and Pacific Market Value Share (%) and BPS Analysis by Disease Indication, 2024 to 2034

Figure 136: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Disease Indication, 2024 to 2034

Figure 137: South Asia and Pacific Market Value (US$ Million) Analysis by End User, 2019 to 2034

Figure 138: South Asia and Pacific Market Volume (Units) Analysis by End User, 2019 to 2034

Figure 139: South Asia and Pacific Market Value Share (%) and BPS Analysis by End User, 2024 to 2034

Figure 140: South Asia and Pacific Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034

Figure 141: South Asia and Pacific Market Attractiveness by Product, 2024 to 2034

Figure 142: South Asia and Pacific Market Attractiveness by Disease Indication, 2024 to 2034

Figure 143: South Asia and Pacific Market Attractiveness by End User, 2024 to 2034

Figure 144: South Asia and Pacific Market Attractiveness by Country, 2024 to 2034

Figure 145: East Asia Market Value (US$ Million) by Product, 2024 to 2034

Figure 146: East Asia Market Value (US$ Million) by Disease Indication, 2024 to 2034

Figure 147: East Asia Market Value (US$ Million) by End User, 2024 to 2034

Figure 148: East Asia Market Value (US$ Million) by Country, 2024 to 2034

Figure 149: East Asia Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 150: East Asia Market Volume (Units) Analysis by Country, 2019 to 2034

Figure 151: East Asia Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 152: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 153: East Asia Market Value (US$ Million) Analysis by Product, 2019 to 2034

Figure 154: East Asia Market Volume (Units) Analysis by Product, 2019 to 2034

Figure 155: East Asia Market Value Share (%) and BPS Analysis by Product, 2024 to 2034

Figure 156: East Asia Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034

Figure 157: East Asia Market Value (US$ Million) Analysis by Disease Indication, 2019 to 2034

Figure 158: East Asia Market Volume (Units) Analysis by Disease Indication, 2019 to 2034

Figure 159: East Asia Market Value Share (%) and BPS Analysis by Disease Indication, 2024 to 2034

Figure 160: East Asia Market Y-o-Y Growth (%) Projections by Disease Indication, 2024 to 2034

Figure 161: East Asia Market Value (US$ Million) Analysis by End User, 2019 to 2034

Figure 162: East Asia Market Volume (Units) Analysis by End User, 2019 to 2034

Figure 163: East Asia Market Value Share (%) and BPS Analysis by End User, 2024 to 2034

Figure 164: East Asia Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034

Figure 165: East Asia Market Attractiveness by Product, 2024 to 2034

Figure 166: East Asia Market Attractiveness by Disease Indication, 2024 to 2034

Figure 167: East Asia Market Attractiveness by End User, 2024 to 2034

Figure 168: East Asia Market Attractiveness by Country, 2024 to 2034

Figure 169: Middle East and Africa Market Value (US$ Million) by Product, 2024 to 2034

Figure 170: Middle East and Africa Market Value (US$ Million) by Disease Indication, 2024 to 2034

Figure 171: Middle East and Africa Market Value (US$ Million) by End User, 2024 to 2034

Figure 172: Middle East and Africa Market Value (US$ Million) by Country, 2024 to 2034

Figure 173: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 174: Middle East and Africa Market Volume (Units) Analysis by Country, 2019 to 2034

Figure 175: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 176: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 177: Middle East and Africa Market Value (US$ Million) Analysis by Product, 2019 to 2034

Figure 178: Middle East and Africa Market Volume (Units) Analysis by Product, 2019 to 2034

Figure 179: Middle East and Africa Market Value Share (%) and BPS Analysis by Product, 2024 to 2034

Figure 180: Middle East and Africa Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034

Figure 181: Middle East and Africa Market Value (US$ Million) Analysis by Disease Indication, 2019 to 2034

Figure 182: Middle East and Africa Market Volume (Units) Analysis by Disease Indication, 2019 to 2034

Figure 183: Middle East and Africa Market Value Share (%) and BPS Analysis by Disease Indication, 2024 to 2034

Figure 184: Middle East and Africa Market Y-o-Y Growth (%) Projections by Disease Indication, 2024 to 2034

Figure 185: Middle East and Africa Market Value (US$ Million) Analysis by End User, 2019 to 2034

Figure 186: Middle East and Africa Market Volume (Units) Analysis by End User, 2019 to 2034

Figure 187: Middle East and Africa Market Value Share (%) and BPS Analysis by End User, 2024 to 2034

Figure 188: Middle East and Africa Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034

Figure 189: Middle East and Africa Market Attractiveness by Product, 2024 to 2034

Figure 190: Middle East and Africa Market Attractiveness by Disease Indication, 2024 to 2034

Figure 191: Middle East and Africa Market Attractiveness by End User, 2024 to 2034

Figure 192: Middle East and Africa Market Attractiveness by Country, 2024 to 2034